Close Menu

NEW YORK (GenomeWeb) – Signature Science said yesterday that it has been awarded a contract from the US Centers for Disease Control and Prevention to evaluate and develop molecular tools to detect and follow the spread of specific bacteria and microbial communities in healthcare settings.

Brian Schimmoller, vice president at Austin, Texas-based Signature Science, noted in an email that the 12-month contract has a value of approximately $560,000.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.

Aug
28
Sponsored by
Horizon Discovery

This webinar will provide an overview of alternatives to the popular Cas9 nuclease used in CRISPR gene editing.